ONE-TWENTY TWO: Trading Financial Markets
Exploring the poetry in financial markets for students of money and economy since the year 2000.
(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more
(This is an excerpt from an article I originally published on Seeking Alpha on October 19, 2016. Click here to read the entire piece.) Mylan (MYL) is down 13% (and as much as 17%) since I argued the company was “out of tune” with an angry chorus that promised to place a lot of short-term … Read more
Drug corporations' greed is unbelievable. Ariad has raised the price of a leukemia drug to almost $199,000 a year. https://t.co/EB4nEPxP2G — Bernie Sanders (@SenSanders) October 14, 2016 The drug industry is getting very, very nervous. We are going to take them on and lower the cost of medication across this country. https://t.co/6PeiLJnR0F — Bernie Sanders … Read more
Gold and silver may have finally topped out. The first technical clues came after SPDR Gold Shares (GLD) reversed all its incremental gains form the post-Brexit trade. I used that event and other indicators to posit a top for gold in late July. GLD promptly bounced from that support level. A month later I reiterated … Read more
(This is an excerpt from an article I originally published on Seeking Alpha on September 25, 2016. Click here to read the entire piece.) Source: UK Government Nothing shows better the edginess of traders than a quick trigger reaction to rumored news. On Friday, September 16 rumors ripped through the news headlines that the UK’s … Read more